Deep Breaths: Updates from CHEST: Recent Episodes
ReachMD
Welcome to the Deep Breaths: Updates from CHEST series, dedicated to championing the prevention, diagnosis, and treatment of lung and chest diseases. Check out CHEST leaders and advocates sharing the latest in chest medicine education, clinical research, and team-based care in the areas of pulmonary diseases, critical care, and sleep medicine. Learn more about the latest diagnostic and treatment advances in pulmonology and critical care below. In Partnership with
Guest: Ashwin Basavaraj, MD
Guest: Keren Bakal, MD
Guest: Nathan Falk, MD, MBA, FAAFP
Guest: Amy Springer, NP
Often mistaken for COPD or asthma, bronchiectasis and nontuberculous mycobacteria (NTM) can be difficult to recognize and test for, often delaying diagnosis and effective treatment. However, an emphasis on education and research can help address these diagnostic gaps, and involving a multidisciplinary care team can improve treatment plans and patient outcomes. Joining Dr. Ashwin Basavaraj, Associate Professor of Medicine at NYU Grossman School of Medicine, to talk about how we can optimize the diagnosis and management of bronchiectasis and NTM are Dr. Keren Bakal, Dr. Nathan Falk, and Ms. Amy Springer. Dr. Bakal is a pulmonologist specializing in critical care medicine at Overlook Medical Center and Morristown Medical Center in New Jersey, Dr. Falk is a Professor and the founding Residency Director for Family Medicine at Florida State University, and Ms. Springer is a Senior Nurse Practitioner at NYU Langone Health.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Isaretta Riley, MD, MPH
Guest: Nicola A. Hanania, MD, MS, FCCP
Guest: Jay Peters, MD
A recent study assessing the impact of implicit bias on uncontrolled asthma treatment found that a patient’s identity and socioeconomic status can unintentionally influence a physician’s decision-making, impacting the quality of care. Additionally, a critical gap exists in clinician awareness and implementation of health equity practices, which play a key role in mitigating these unintended consequences. That’s why Drs. Isaretta Riley, Nicola Hanania, and Jay Peters come together to explore the latest research on unconscious bias in asthma treatment and provide recommendations for more equitable care. Dr. Riley is an Assistant Professor of Medicine at Duke University School of Medicine in Durham, North Carolina; Dr. Hanania is a Professor of Pulmonary Medicine and the Director of Airways Clinical Research Center at Baylor College of Medicine in Houston, Texas; and Dr. Peters is a Professor Emeritus of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of Texas, San Antonio.
This episode of Deep Breaths: Updates from CHEST was supported by a non-promotional, non-CME educational program brought to you by CHEST in collaboration with and sponsored by GSK.
Guest: Ryan Maves, MD
Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN
Although there have been several advances in vaccine technology and safety the past few years, the prevalence of vaccine hesitancy among patients is increasing. Since vaccine hesitancy heightens the burden of potentially life-threatening viruses like RSV and influenza, Dr. Ryan Maves speaks with Dr. Susan Corbridge about why patients might be reluctant to get vaccinated and how we can use the First 5 Minutes approach to provide individualized counseling on the importance of vaccines. Dr. Maves is a Professor of Medicine and Anesthesiology in the Sections of Infectious Diseases and Critical Care Medicine at the Wake Forest University School of Medicine, and Dr. Corbridge is a Professor Emerita at the University of Illinois at Chicago College of Nursing.
This episode is supported by an educational grant from Moderna.
Host: Angela Birdwell, DO, MA, FCCP
Guest: Antonio Anzueto, MD
Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN
Although the prevalence of chronic obstructive pulmonary disease (COPD) has decreased in adults aged 18 to 44, it remains elevated in certain patient groups, like women, adults over 65, smokers, and those living in rural areas. This prevalence emphasizes the importance of a patient-centered approach, which is why Dr. Angela Birdwell speaks with Drs. Antonio Anzueto and Susan Corbridge about how open conversations and the First 5 Minutes concept can help personalize the care of COPD patients and lead to better outcomes. Dr. Anzueto is a Professor of Medicine at the South Texas Veterans Health Care System and UT Health San Antonio, and Dr. Corbridge is the Chief Essentials Program Officer at the American Association of Colleges of Nursing and a Professor Emerita at the University of Illinois at Chicago College of Nursing.
This non-CME education is brought to you by CHEST, and this program is supported by Regeneron Pharmaceuticals, Inc. and Sanofi.
Host: Farrukh Abbas, MD
Guest: Megan Conroy, MD, MA(Ed)
Listen in as Farrukh Abbas, MD, FCCP, and Megan Conroy, MD, MAEd, FCCP, discuss the role of the care team in COPD diagnosis, recent changes in classifications and updates to the GOLD guidelines, how triple-inhaler therapies and biologics can be used to treat patients with COPD, and more.
Since the time of this recording, the FDA has recently approved dupilumab as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) with type 2 inflammation.
Host: Tom Corbridge, MD, FCCP
Guest: De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP
Guest: Diego Maselli, MD
Guest: Praveen Akuthota, MD
As we continue to learn more about the underlying inflammatory pathways in asthma, we now have more novel tools and treatments to help us achieve control, remission, and better outcomes for our patients. But in order to achieve those goals, we must first detect severe asthma early enough to take full advantage of the latest advancements. Learn more about the importance of early detection and intervention in severe asthma care through the lens of a real-world patient case with Drs. Tom Corbridge, De De Gardner, Diego Maselli, and Praveen Akuthota. This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Demondes Haynes, MD
Guest: Njira Lugogo, MD
Guest: Neil Skolnik, MD
According to data from the CDC, over half of patients in the United States are not considered well controlled, and there hasn’t been much improvement in exacerbations as measured by ER visits or by deaths per year in the last 30 years or so. But fortunately, the use of single maintenance and reliever therapy (SMART) has been shown to help address inflammation and decrease exacerbations. Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik discuss this approach and other combination treatment for asthma. This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.
Host: Demondes Haynes, MD
Guest: Njira Lugogo, MD
Guest: Neil Skolnik, MD
Expert opinions from NAEPP and GINA recommend treating both symptoms and inflammation in asthma patients concomitantly. Joining Dr. Demondes Haynes to talk about these updates and therapies for asthma like short-acting beta agonists and inhaled corticosteroids are Drs. Njira Lugogo and Neil Skolnik.
This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.
Host: Demondes Haynes, MD
Guest: Njira Lugogo, MD
Guest: Neil Skolnik, MD
When it comes to managing acute asthma symptoms and reducing risk for patients, our focus is now on relieving bronchoconstriction and inflammation. Given this fundamental change, it’s important to ensure that our patients understand this shift. Find out how taking a shared decision-making approach can help patients embrace this change in addition to improving their adherence and outcomes with Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik.
This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.
Guest: Stephen Doyle, DO, MBA, FCCP
Guest: Navitha Ramesh, MD, FCCP
Host: Sandhya Khurana, MD, FCCP
The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes
Guest: Sandhya Khurana, MD, FCCP
Guest: Navitha Ramesh, MD
Guest: Stephen Doyle, DO, MBA, FCCP
The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal
available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes.
Host: Ryan Maves, MD
Guest: Megan Conroy, MD, MA(Ed)
Respiratory syncytial virus (RSV) is most commonly recognized for the significant disease it causes in infants and young children. However, over time its prevalence in adults has increased. Tune in to learn more with Dr. Ryan Maves as he speaks with Dr. Megan Conroy, Assistant Professor of Medicine at the Ohio State University in Columbus.
This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.
Host: Ryan Maves, MD
Guest: Kelly Pennington, MD
It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.
This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.
Host: Ryan Maves, MD
Guest: Kelly Pennington, MD
It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.
Guest: Ashwin Basavaraj, MD
Host: Christopher Lippincott, MD, MPH
From airway clearance techniques and mucoactive therapy—what can clinicians do to manage bronchiectasis exacerbations? To answer this question, Dr. Christopher Lippincott and Dr. Ashwin Basavaraj explore the mechanisms that lead to bronchiectasis and share strategies to manage exacerbations.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Ashwin Basavaraj, MD
Guest: Christopher Lippincott, MD, MPH
Bronchiectasis is a complex syndrome that can lead to an interconnected cascade of airway dysfunction and inflammation. How has our understanding of this syndrome evolved with Cole’s vicious cycle hypothesis? Dr. Ashwin Basavaraj and Dr. Christopher Lippincott take a closer look at this hypothesis and the clinical mechanisms behind bronchiectasis.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Navitha Ramesh, MD, FCCP
Guest: Allen Blaivas, DO
When selecting the right delivery device for your patient with COPD, there are a lot of factors to consider. To help us better understand these key components, Dr. Navitha Ramesh and Dr. Allen Blaivas from the Rutgers New Jersey Medical School discuss nebulizer therapy, delivery devices, and patient education.
This is a non-promotional, non-CME disease state educational program brought to you by CHEST. Sponsored by Theravance BioPharma and Viatris.
Host: Randy Young, MD
Guest: Tufik Assad, MD, MSCI
What are the factors that make diagnosing pneumonia challenging, and how might emerging testing modalities improve that? To answer this question, Dr. Randy Young and Dr. Tufik Assad from the Williamson Medical Center in Franklin, Tennessee dive into the etiology, diagnostic challenges, and current trends in pneumonia diagnostics.
This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.
Host: Randy Young, MD
Guest: Daniel Jay Feinstein, MD, FACP, MS, ACRP-PI
Diagnosing pneumonia can be challenging, but the CAP guidelines offer recommendations to improve the detection of this infection. To find out more about the recommendations, Dr. Randy Young and Dr. Daniel Feinstein, a Physician Executive at Novant Health, dive into testing for pneumonia.
This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.
Host: David Schulman, MD, MPH, FCCP
Guest: William Lago, MD
Guest: Tejaswini Kulkarni, MD, MPH, FCCP
What are some of the barriers to early diagnosis for idiopathic pulmonary fibrosis (IPF)? Joining Dr. David Schulman to share their perspectives on the latest diagnostic challenges and provide strategies to combat them are Drs. Tejaswini Kulkarni and William Lago.
This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by Three Lakes Foundation.
Host: Frank C. Sciurba, MD, FCCP
Guest: Emily L. Yee, MD
What do we need to know about using endobronchial valves in patients with severe COPD and emphysema? Drs. Frank Sciurba and Emily Yee explore the impact of these valves on patients.
This educational podcast is produced in partnership with the American College of CHEST Physicians and sponsored by Pulmonx Corporation, the manufacturer of Zephyr. Click here to find additional educational resources for clinicians and patients.
Host: Ashwin Basavaraj, MD
Nontuberculous mycobacteria (NTM) and bronchiectasis are challenging diseases that require a multidisciplinary approach to treat. Dr. Ashwin Basavaraj sits down with his patient, Mary, to learn more about these obstacles and discuss how we can find the right care team.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Doreen Addrizzo-Harris, MD
Guest: Ashwin Basavaraj, MD
From evaluating diagnostic criteria to nonpharmacologic therapy, what do the NTM guidelines recommend when it comes to the treatment of MAC lung disease? Drs. Doreen Addrizzo-Harris and Ashwin Basavaraj from NYU Grossman School of Medicine will dive into the practical application of the NTM guidelines.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Narjust Duma, MD
Guest: Janani Reisenauer, MD
Guest: Colleen Channick, MD, FCCP, DAABIP
A multidisciplinary panel including a medical oncologist, a thoracic surgeon, and an interventional pulmonologist will discuss the role of lung cancer teams in their thoracic oncology practices. The panelists will review their management of patients with lung cancer during the COVID-19 pandemic, including the impact of delayed procedures and telemedicine on patient outcomes.
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Narjust Duma, MD
Guest: Andreas Rimner, MD
Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers.
Host: Eric Edell, MD, FCCP
Host: Septimiu Murgu, MD, FCCP
Guest: Narjust Duma, MD
Guest: Christopher Hartley, MD
Guest: Jeffrey Mueller, DO
Expert pathologists and a medical oncologist will discuss current guidelines and their own practices regarding the role of liquid biopsy and comprehensive genetic and PD-L1 testing in the management of advanced lung cancer. The panelists will also explore various strategies for optimizing the quantity and quality of cytology and small volume biopsy specimens.
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Nichole Tanner, MD, MS, FCCP
Guest: Fabien Maldonado, MD, FCCP
Two internationally known interventional pulmonologists will discuss current guidelines and their own experiences regarding sampling of lung lesions and mediastinal adenopathy. Specifically, the panelists will discuss the pros and cons of various diagnostic strategies and sampling techniques, including transcutaneous and bronchoscopic biopsies. This interactive webinar will offer the opportunity for learners to ask questions prior to and during the event. Learning is augmented by a few follow-up quizzes weeks after the webinar, a strategy proven to improve knowledge gain and retention.
Host: David Schulman, MD, MPH, FCCP
Guest: Andrew H. Limper, MD
Guest: Timothy A. Hernandez, MD
There are many barriers to reaching a definitive diagnosis for idiopathic pulmonary fibrosis (IPF). To learn more about these obstacles—and how we can overcome them—Dr. David Schulman from the American College of Chest Physicians joins Dr. Tim Hernandez from the University of Texas Health Sciences Center and Dr. Andrew Limper from the Mayo Clinic to discuss the diagnosis of IPF.
This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by Three Lakes Foundation.
https://info.chestnet.org/bridging-specialties-timely-diagnosis-for-ild-patients
Guest: Peter Howarth BSc, (Hons), MBBS, DM, FRCP
Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci
Guest: Geoffrey Chupp, MD
Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford.
This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Muhammad Adrish MD, MBA, FCCP, FCCM
Guest: Navitha Ramesh, MD, FCCP
Inhalers are one of the most common methods of delivery for the treatment of COPD, but is it the best option for all of our patients? Associate Professor of Pulmonary Critical Care at Baylor College of Medicine, Dr. Muhammad Adrish, reviews LAMA use for COPD patients with Dr. Navitha Ramesh, Assistant Professor at Drexel University College of Medicine.
This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.
Host: Megan Conroy, MD, MA(Ed)
Guest: Farrukh Abbas, MD
On average, more than two-thirds of patients with chronic obstructive pulmonary disease (COPD) make at least one error in using an inhaler device. Fortunately, nebulized long-acting muscarinic antagonists (LAMAs) can help our patients overcome this common challenge in COPD care. That’s why Drs. Megan Conroy and Farrukh Abbas come together to talk about the GOLD treatment guidelines, strategies for reducing patient hesitancy regarding nebulized LAMAs, and more.
This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.
Guest: Jared Nathan Silver, MD, PhD
Guest: Praveen Akuthota, MD
Eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndromes are often mistaken for each other. How can we better distinguish these diseases? Dr. Jared Silver discusses how to diagnose these diseases with Dr. Praveen Akuthota, a pulmonologist from U.C. San Diego Medical Center in California.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Lisa K Moores, MD, FCCP, MACP
Guest: David Jiménez MD, PhD, FERS
Guest: Geert-Jan Geersing MD, PhD
Physicians are challenged in adopting the latest clinical guidelines and integrating new and existing treatment advances into practice when managing patients with VTE.
Host: Tom Corbridge, MD, FCCP
Guest: Michael E. Wechsler, MD, MMSc
Severe asthma is an uncontrolled disease that can be difficult to diagnose. To help us overcome this obstacle, Dr. Tom Corbridge joins Dr. Michael Wechsler from National Jewish Health in Denver to discuss the challenges we face while trying to diagnose severe asthma.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Lisa Baumann Kreuziger, MD, MS
Guest: Marc Carrier MD, FRCPC
Guest: Rachel P. Rosovsky, MD, MPH
Although evidence corroborates the safety and efficacy of managing low-risk patients with VTE in outpatient settings through prophylactic extension, the majority of this subtype is still being treated in hospital settings.
Host: Stavros Konstantinides, MD, FRCP (Glasg)
Guest: Riyaz Bashir MD, FACC
Guest: Akhilesh Sista, MD, FSIR, FAHA
High risk patients and those with identifiable symptoms are not routinely receiving prophylaxis treatment that could prevent the development of VTE.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Hassan Bencheqroun, MD
Evaluating the need for therapy escalation can be challenging. So joining Dr. Charles Turck to help us understand how to escalate treatment for patients with chronic obstructive pulmonary disease is Dr. Hassan Bencheqroun, Assistant Professor of Medicine at the University of California Riverside School of Medicine.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Deborah Levine, MD, FCCP
To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Chitra Lal, MD
Dr. Charles Turck is joined by Dr. Chitra Lal, a Professor of Medicine at the Medical University of South Carolina in Charleston, to share strategies for adherence to treatment and discuss multiple versus single inhaler triple therapy for COPD.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Michael E. Greenberg, MD, MPH
Guest: Randy Young, MD
Despite widespread eligibility, only half of Americans received their flu vaccine last year, and only 55% have been fully vaccinated against COVID-19. Dr. Randy Young joins host Dr. Michael Greenberg to discuss the latest coadministration guidelines and how they could impact vaccination rates.
This episode is produced in partnership with the American College of CHEST Physicians and sponsored by Sanofi Pasteur.
Host: Fernando J Martinez, MD, FCCP
Guest: Navitha Ramesh, MD, FCCP
At least 50 percent of our patients with asthma continue to experience uncontrolled asthma, and they remain at risk of asthma exacerbations, which can be serious. To learn more about the impacts of uncontrolled asthma, Dr. Fernando J. Martinez sits down with Dr. Navitha Ramesh, who discusses how we can better diagnose, assess, and treat this condition.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline
Host: Matthew P. Bars, MS, CTTS, NCTTP
Guest: Michael C. Fiore, MD, MPH, MBA
Guest: Laura E. Crotty Alexander, MD
Dr. Matt Bars is joined by his two colleagues: Dr. Laura Crotty Alexander, Associate Professor of Pulmonary Critical Care Medicine at the University of California San Diego, and Dr. Michael Fiore, Professor of Medicine at the University of Wisconsin and Director of the University of Wisconsin Center for Tobacco Research Intervention. Together, they review tobacco dependence, the CHEST Tobacco Dependence Treatment Toolkit, and resources to help patients.
Supported in part by an independent medical educational grant from Pfizer.
Host: Gerard A. Silvestri MD, MS, FCCP
Guest: Lynn Tanoue, MD, MBA
About 10 percent of all cancer patients develop treatment-related pulmonary complications, and for lung cancer patients, that risk is even greater. Dr. Gerard Silvestri sits down with Dr. Lynn Tanoue, Professor of Medicine and Vice Chair of Clinical Affairs in the section of pulmonary critical care and sleep medicine at the Yale Cancer Center in New Haven, Connecticut, to discuss pulmonary toxicities related to lung cancer treatment.
Host: Gerard A. Silvestri MD, MS, FCCP
Guest: Michael S. Machuzak, MD
Clinicians can uncover a wealth of information from a non-small cell lung cancer patient’s collected tissue that can help inform treatment decisions. To dive into this idea further, Dr. Gerard Silvestri is joined by his colleague Dr. Michael Machuzak, Full Staff Member in the Department of Pulmonary, Allergy, and Critical Care Medicine at Cleveland Clinic. Together they review the importance of tissue acquisition, proper handling of specimens, rapid onsite evaluation during EBUS-TBNA procedures, and much more.
Host: Gerard A. Silvestri MD, MS, FCCP
Guest: Catherine R. Sears, MD
When it comes to managing lung cancer, should we be considering a multidisciplinary approach? Dr. Gerard Sylvestri is joined by Dr. Katie Sears, an assistant professor at the Indiana University School of Medicine, to discuss multidisciplinary lung cancer programs and share suggestions on how to implement this kind of approach.
Host: Gerard A. Silvestri MD, MS, FCCP
Guest: Lonny Brett Yarmus, DO, FCCP
Dr. Gerard Sylvestri, the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina in Charleston and Dr. Lonny Yarmus, Clinical Director of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University, come together to discuss staging in early-stage lung cancer.
An educational campaign brought to you by CHEST, in collaboration with AstraZeneca.
Host: De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP
Guest: Stephanie Briney, DO
Despite widespread availability, only half of Americans received the flu shot last year. With that in mind, Dr. De De Gardner is joined by Dr. Stephanie Briney, Assistant Professor in Family, Community, and Preventive Medicine at the University of Arizona College of Medicine, Phoenix to discuss why Americans avoid getting the flu shot and how she approaches this in her practice.
Host: Timothy Aksamit, MD
Guest: Amy Levinger, MSN, FNP-C
Guest: David E. Griffith, MD
The prevalence of non-tuberculous mycobacterial (NTM) lung disease in the United States has almost doubled between 2008 and 2015. But despite this increase, its diagnosis can often be delayed, which is why pulmonary nurse practitioner Amy Levinger and Dr. David Griffith join Dr. Tim Aksamit to discuss the diagnostic criteria, tools that can help us make a timely diagnosis of NTM lung disease, and more.
For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Xavier Soler, MD, PhD
Guest: Nicola A. Hanania, MD, MS, FCCP
To help us address the current lack of awareness of uncontrolled or symptomatic asthma in all stages of the disease, Dr. Xavier Soler is joined by Dr. Nicola Hanania, Associate Professor of Pulmonary Medicine and Director of the Airway Clinical Research Center at Baylor College of Medicine in Houston, Texas. Together, they’ll discuss how we can better recognize and treat our patients with uncontrolled asthma.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
Host: David E. Griffith, MD
Guest: Amy Levinger, MSN, FNP-C
Guest: Timothy Aksamit, MD
The care team supporting a patient with mycobacterium avium complex, or MAC, lung disease is just as important as the treatment itself. Joining Dr. David Griffith to discuss how we can provide optimal treatment using established guideline-based strategies all while protecting patients’ quality of life are Dr. Tim Aksamit and pulmonary nurse practitioner Amy Levinger.
For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Megan Carreon, MHA, RRT
Guest: Amy Levinger, MSN, FNP-C
Guest: Timothy Aksamit, MD
There are numerous factors that contribute to an overall wellness of patients with of NTM refractory MAC lung disease. Listen in as Megan Carreon, Assistant Professor with the Division of Respiratory Care at UT Health San Antonio, Texas, sits down with pulmonary nurse practitioner Amy Levinger from NYU Langone Health and Dr. Tim Aksamit, Associate Professor of Pulmonary and Critical Care Medicine at Mayo Clinic.
For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Host: Tom Corbridge, MD, FCCP
Guest: Matt Hegewald, MD FCCP
With uncontrolled asthma placing such a tremendous burden on our patients and our society, how can we use the latest treatment guidelines to help alleviate that burden? Dr. Matt Hegewald is here to talk about the new and emerging guideline-based treatments for uncontrolled asthma, like long-acting muscarinic antagonists.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
Host: Tom Corbridge, MD, FCCP
Guest: Navitha Ramesh, MD, FCCP
Now that long-acting muscarinic receptor antagonists (LAMAs) have entered the scene, Dr. Tom Corbridge is joined by Dr. Navitha Ramesh, a pulmonologist and critical care physician at UPMC, to review some patient cases demonstrating how LAMAs may be changing the way we approach step-up treatment for some patients with asthma.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
Host: Tom Corbridge, MD, FCCP
Guest: Gary T. Ferguson, MD, F.C.C.P
Listen in as Dr. Tom Corbridge and Dr. Gary Ferguson discuss the challenges physicians and patients face when there is an underreporting of COPD symptoms. Together, they’ll also explore the ways physicians can overcome these obstacles and give their patients the appropriate treatment.
This episode is supported in part by an unrestricted/independent medical educational grant from GlaxoSmithKline.
Host: Nicola A. Hanania, MD, MS, FCCP
Guest: Neil J. Freedman, MD
Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.
Host: Anoop Nambiar, MD
Guest: Joshua Mooney, MD, MS
At the 2019 CHEST annual conference, Dr. Anoop Nambiar got a chance to catch up with Dr. Joshua Mooney, who highlighted the conference’s key takeaways on interstitial lung disease, like recently developed screening tools, lung transplant technologies, self-care strategies for patients, and more.
Along with strategies and the latest treatment approaches, Drs. Nambiar and Mooney will discuss clinically relevant suggestions that healthcare providers can start to use today in patients with ILD.
This episode is supported in part by an unrestricted/independent medical educational grants from the following: Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.
Host: Kristina Montemayor, MD
Guest: Natalie E. West, MD
Guest: Allison Lambert, MD
Drs. Natalie West and Allison Lambert join Dr. Kristina Montemayor on the floor of the 2019 CHEST annual conference to talk about the sweat chloride test, CFTR modulator therapies, and other emerging strategies for diagnosing and treating patients with cystic fibrosis.
In this episode, Drs. West, Lambert, and Montemayor will share what clinicians should do to improve our patients with cystic fibrosis.
This episode is supported in part by an unrestricted/independent medical educational grants from the following: Chiesi USA, Inc., Mylan Specialty, and Vertex Pharmaceuticals Incorporated.
Host: Sandhya Khurana, MD, FCCP
Guest: Monica Kraft, MD, FCCP
Recorded live at the 2019 annual CHEST conference in New Orleans, Dr. Monica Kraft joins Dr. Sandhya Khurana to talk about how the new available biologics are going to fit into the severe asthma treatment landscape along with other highlights from the conference.
Find out what Dr. Khurana and Dr. Kraft think you should do right now to improve treatment of severe asthma! This episode is supported in part by an unrestricted/independent medical educational grants from the following: Genentech, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation.